Earnings · China A-shares
Huaren Pharmaceutical Co., Ltd. Class A (300110) earnings
Huaren Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit -50.69% year on year, -50.65% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -4.15% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- -50.69%
- Excl. one-offs YoY
- -50.65%
- Net profit QoQ
- -112.94%
- Result
- Bad / loss
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.13% | — |
| 3 days | -4.15% | — |
| 7 days | +2.64% | — |
| 14 days | -3.02% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 4 of 6 reports (average +0.55%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥26.91M | -50.69% | -50.65% | -10.48% | 0.02 | 3.16% | -4.15% | — | — |
| 2026 interim report | 2026-08-27 | ¥28.54M | -23.55% | -8.09% | -3.02% | 0.02 | 3.35% | +0.00% | +3.45% | +12.38% |
| 2026 Q1 report | 2026-04-24 | ¥15.96M | -0.44% | +34.72% | +2.14% | 0.01 | 1.89% | +0.98% | -12.13% | -12.55% |
| 2025 annual report | 2026-04-24 | -¥462.90M | +66.17% | +65.88% | -2.34% | -0.39 | -43.29% | +0.98% | -12.13% | -12.55% |
| 2025 Q3 report | 2025-10-30 | ¥54.58M | -42.87% | -49.18% | -9.07% | 0.05 | 4.11% | +3.90% | +0.90% | +5.65% |
| 2025 interim report | 2025-08-16 | ¥37.33M | -49.01% | -59.17% | -19.13% | 0.03 | 2.83% | +2.27% | -8.81% | -17.11% |
| 2025 Q1 report | 2025-04-23 | ¥16.03M | -68.46% | -74.87% | -25.38% | 0.01 | 1.22% | +0.33% | +10.96% | +7.92% |
| 2024 annual report | 2025-04-23 | -¥1.37B | -827.67% | — | -17.30% | -1.16 | -68.58% | +0.33% | +10.96% | +7.92% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.